Neurgain Technologies
Manufacturing · California, United States · 1-10 Employees
View Company Info for Free
Overview
Headquarters
8601 Via Mallorca Unit C, La Jolla, Cali...Phone Number
(858) 405-8850Website
www.neurgaintech.comRevenue
<$5 MillionIndustry
ZI Rank: 1
Signal Type
Jan
Feb
Mar
Apr
May
Jun
ZI Rank
1
1
1
1
1
1
About Neurgain Technologies
Neurgain Technologies is a pioneer in precision neurology, focusing on innovative treatments for damage to the central nervous system and spinal cord. The company addresses the challenges of imprecise medication delivery, enhancing safety and efficacy through advanced therapeutic strategies. Neurgain's flagship gene therapy targets chronic spasticity and neuropathic pain, and they seek licensing partnerships to further improve medication delivery for neural conditions. Their novel subpial vector delivery method allows for flexible and targeted therapeutic applications.Explore more
Neurgain Technologies Org Chart
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is Neurgain Technologies your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Congratulate Masked Content for being promoted to Masked Content at Neurgain Technologies
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Click to see if Neurgain Technologies had a recent Job posting/layoffs
Check out if Neurgain Technologies is spiking on competitors!
Check if Neurgain Technologies has recently received funding, and reach out quickly before it becomes old news!
Product Launch: Get notified when Neurgain Technologies launches new products
Earning: See what the market has to say on Neurgain Technologies recently announced quarterly report
Website visits: Recent activity has been detected on your website
Neurgain Technologies, which may be a good buyer, showed buying intent in Masked Content Topic
Funding: Get notified immidiatlly once Neurgain Technologies has new funding data
Recommended Actions
Find VP level buyers at Neurgain Technologies
Find 2 more new buyers
Compare Similar Companies to Neurgain Technologies
Compare insights from companies similar to Neurgain Technologies, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Company Profile Activity
Activity Insights
Neurgain Technologies is experiencing very low activity levels compared to other companies in the Manufacturing sector.
What does this means?
Neurgain Technologies is drawing exceptional interest within the Manufacturing industry, suggesting notable developments or strong market momentum, learn more about Neurgain Technologies.
Neurgain Technologies Tech Stack
A closer look at the technologies used by Neurgain Technologies
Neurgain Technologies News & Media
Lineage Enters Into Exclusive Agreement with Neurgain Technologies to Evaluate Novel Delivery System for OPC1 to Treat Spinal Cord Injury
CARLSBAD, Calif.--(BUSINESS WIRE)---- $LCTX #CIRM--Lineage Cell Therapeutics, Inc. (NYSE American and TASE: LCTX), a clinical-stage biotechnology company developing allogeneic cell therapies for unmet medical needs, today announced that it has entered into an exclusive option and license agreement with Neurgain Technologies, Inc. (“Neurgain”), a medical device company that is commercializing technology developed by neurosurgeons at the University of California San Diego (“UC San Diego”). Under t
Read more news
Top Manufacturing Companies
Top companies in Canada by revenue
Top companies in Australia by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding Neurgain Technologies
Sign Up For FreeTo access detailed company insights
Neurgain Technologies is a pioneer in precision neurology, focusing on innovative treatments for damage to the central nervous system and spinal cord. The company addresses the challenges of imprecise medication delivery, enhancing safety and efficacy through advanced therapeutic strategies. Neurgain's flagship gene therapy targets chronic spastici... Read More
